Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
Amgen
Amgen
OncoNano Medicine, Inc.
University of Texas Southwestern Medical Center
Amgen
Cairo University
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)